Pacer Advisors, Inc. Bristol Myers Squibb CO Transaction History

Pacer Advisors, Inc.

$38.6 Billion
Q1 2024

A detailed history of Pacer Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pacer Advisors, Inc. holds 9,146,955 shares of BMY stock, worth $380 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares

9,146,955

Previous 7,830,948 16.81%

Holding current value

$380 Million

Previous $402 Million 23.45%

% of portfolio

1.29%

Previous 1.27%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $63.1 Million - $71.6 Million	1,316,007 Added 16.81%	9,146,955 $496 Million
Q4 2023 Jan 16, 2024	BUY	$48.48 - $57.85 $123 Million - $147 Million	2,540,360 Added 48.02%	7,830,948 $402 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $72.4 Million - $80.9 Million	1,249,846 Added 30.93%	5,290,588 $307 Million
Q2 2023 Jul 12, 2023	SELL	$63.71 - $70.74 $530,704 - $589,264	-8,330 Reduced 0.21%	4,040,742 $258 Million
Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $254 Million - $288 Million	3,863,095 Added 2077.19%	4,049,072 $281 Million

Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $137 Million - $162 Million	-1,995,039 Reduced 91.47%	185,977 $13.4 Million
Q3 2022 Oct 18, 2022	BUY	$0.13 - $76.84 $32,705 - $19.3 Million	251,581 Added 13.04%	2,181,016 $155 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $48.4 Million - $53.3 Million	666,543 Added 52.78%	1,929,435 $149 Million
Q1 2022 Apr 05, 2022	BUY	$61.48 - $73.72 $39.6 Million - $47.5 Million	643,750 Added 103.97%	1,262,892 $92.2 Million
Q4 2021 Feb 03, 2022	BUY	$53.63 - $62.52 $8.69 Million - $10.1 Million	162,036 Added 35.45%	619,142 $38.6 Million
Q3 2021 Oct 15, 2021	BUY	$59.17 - $69.31 $4.01 Million - $4.7 Million	67,741 Added 17.4%	457,106 $27 Million
Q2 2021 Jul 21, 2021	BUY	$61.91 - $67.42 $7.63 Million - $8.31 Million	123,246 Added 46.31%	389,365 $26 Million
Q1 2021 Apr 05, 2021	BUY	$59.34 - $66.74 $385,472 - $433,543	6,496 Added 2.5%	266,119 $16.8 Million
Q4 2020 Jan 20, 2021	BUY	$57.74 - $65.43 $1.09 Million - $1.23 Million	18,874 Added 7.84%	259,623 $16.1 Million
Q3 2020 Oct 19, 2020	BUY	$57.43 - $63.64 $2.44 Million - $2.71 Million	42,560 Added 21.47%	240,749 $14.5 Million
Q2 2020 Jul 29, 2020	BUY	$54.82 - $64.09 $10.9 Million - $12.7 Million	198,189 New	198,189 $11.7 Million
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $12.6 Million - $18.3 Million	-271,371 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$49.21 - $64.19 $374,340 - $488,293	-7,607 Reduced 2.73%	271,371 $17.4 Million
Q3 2019 Oct 10, 2019	BUY	$42.77 - $50.71 $716,867 - $849,950	16,761 Added 6.39%	278,978 $14.1 Million
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $5.2 Million - $5.75 Million	116,476 Added 79.92%	262,217 $11.9 Million
Q1 2019 Apr 10, 2019	BUY	$45.12 - $53.8 $6.58 Million - $7.84 Million	145,741 New	145,741 $6.95 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $7.53 Million - $9.76 Million	-154,387 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $998,883 - $1.13 Million	18,099 Added 13.28%	154,387 $9.58 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $3.75 Million - $4.68 Million	74,230 Added 119.61%	136,288 $7.54 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $417,342 - $480,445	6,965 Added 12.64%	62,058 $3.93 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $791,208 - $862,619	13,200 Added 31.51%	55,093 $3.38 Million
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $2.31 Million - $2.67 Million	41,893	41,893 $2.67 Million

Others Institutions Holding BMY

# of Institutions

2,554

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Bristol Myers Squibb CO Transaction History